When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XLRN - Gossamer Bio: Circling Back After A Rebound Off Lows
Acceleron Pharma Inc.
Shares of Gossamer Bio have rebounded some 75% off their lows set in mid-July and have pivoted away from its failed asthma asset GB001.
Merck’s $11 billion overture for Acceleron and its PAH candidate (sotatercept), in addition to positive commentary from Piper have also boosted Gossamer’s stock price.
The relative lack of hard efficacy data for Gossamer’s current clinical compounds will end with two Phase 2 readouts in 1H22, merited a deeper dive into this busted IPO.